# OnCo record gvhd (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/gvhd/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "gvhd" ;
  schema:name "Graft-versus-host disease (GVHD) and graft-versus-leukaemia"@en ;
  schema:alternateName "GVHD"@en, "GvHD"@en, "graft-versus-host"@en, "graft-versus-host disease"@en, "acute GVHD"@en, "chronic GVHD"@en, "cGVHD"@en, "aGVHD"@en, "steroid-refractory GVHD"@en, "graft-versus-leukaemia"@en, "graft-versus-leukemia"@en, "GVL"@en, "graft-versus-tumour"@en, "GVHD prophylaxis"@en ;
  schema:description "After a donor transplant, the donor's immune cells may attack the patient's skin, gut and liver (graft-versus-host disease) while also hunting down leftover leukaemia (graft-versus-leukaemia). The two effects are linked, so doctors try to keep enough of the second without too much of the first."@en ;
  schema:url <https://onco.cc/terms/gvhd/> ;
  schema:dateModified "2026-09-09"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Graft-versus-host_disease> ;
  schema:citation <https://en.wikipedia.org/wiki/Graft-versus-host_disease> ;
  onco:related <https://onco.cc/terms/allogeneic-transplant/>, <https://onco.cc/terms/conditioning-regimen/>, <https://onco.cc/terms/irae/>, <https://onco.cc/terms/crs/>, <https://onco.cc/technologies/gvhd-chronic-overview/>, <https://onco.cc/technologies/gvhd-nih-consensus-criteria/>, <https://onco.cc/technologies/gvhd-organ-by-organ/>, <https://onco.cc/technologies/gvhd-lung-bronchiolitis-obliterans/>, <https://onco.cc/technologies/gvhd-prophylaxis/>, <https://onco.cc/technologies/gvhd-ruxolitinib-steroid-refractory/>, <https://onco.cc/technologies/gvhd-belumosudil-axatilimab-ibrutinib/>, <https://onco.cc/technologies/gvhd-photopheresis/> ;
  onco:sections <https://onco.cc/fronts/cell-therapy/>, <https://onco.cc/fronts/rejuvenation/> ;
  onco:drugs <https://onco.cc/drugs/ruxolitinib/>, <https://onco.cc/drugs/belumosudil/>, <https://onco.cc/drugs/ibrutinib/> .